See other companies on Welcome to the Jungle

Benchling

Cloud-based platform for biotech R&D

Benchling logo
501-1000 employees
  • B2B
  • SaaS
  • Science
  • Biotechnology
Yerba Buena, San Francisco, CA

Company mission

To unlock the power of biotechnology and empower their global customers to get to milestones & market faster.

Top investors

Some candidates hear
back within 2 weeks

-3% employee growth in 12 months

Our take

As the pioneer of the R&D Cloud, Benchling offers a cloud-based informatics platform tailored for biotechnology. Its platform enables scientists across the globe to make breakthrough discoveries and bring next-gen biotechnology to market.

There’s a sincerity and consciousness to Benchling’s approach that stands out. This has led to the company being adopted by over 200,000 scientists from 1,000+ companies and 7,500 academic and research institutions globally (including 23andMe, Moderna, and the U.S. Department of Defense).

The rapidly advancing Biotechnology industry was at the forefront of the so-called “fourth industrial revolution”, with the industry driving $2 to $4 trillion per year of economic impact over the next 20 years.

Benchling has put itself in a position of immense value within the industry with its expanding offerings. Off the back of over $400 million in total funding, the company is seeing accelerated growth

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • 4 months paid parental leave
  • 401k plan
  • Pre-tax commuter benefits
  • Flexible paid time off
  • Work from home opportunities
  • 100% premiums covered for health, dental, & vision
  • Fertility healthcare and family-forming benefits

Company values

  • Constant Curiosity - Like the scientists we serve, we approach life with a sense of constant curiosity
  • Scientist First - We’re relentlessly focused on taking a scientist-first approach
  • Impact Driven - We commit our time, energy, and resources to efforts that will drive maximum impact

Funding (last 2 of 8 rounds)

Nov 2021

$100m

SERIES F

Apr 2021

$200m

SERIES E

Total funding: $411.9m

This company has top investors

Leadership

Sajith studied at MIT before spending 2 years as a Research Assistant at Duke University Medical Centre and Liquidia Technologies. They used this biotechnology understanding to found Benchling in June 2012, serving as CEO since.

Ashu Singhal

(President)

They previously co-founded Hotspots.io which was later acquired by Twitter in 2012. After this, became Staff Software Engineer at Twitter for 2 years, leaving to co-found Benchling.

Jobs (11)

All locations

Marketing

Finance, Legal & Compliance